18F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment

Journal of Nuclear Medicine

Volumn 55, Issue 1, 2014, Pages 30-36

  Lizarraga, Karlo J ^a   Allen Auerbach, Martin ^b   Czernin, Johannes ^b   DeSalles, Antonio A F ^b   Yong, William H ^b   Phelps, Michael E ^b   Chen, Wei ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain metastases; Radiation injury; Radiation treatment; Tumor recurrence

Indexed keywords

6 FLUORODOPA F 18; CORTICOSTEROID; DIAGNOSTIC AGENT; DOPA; DRUG DERIVATIVE; FLUORINE;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION INJURY; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STEREOTACTIC BODY RADIATION THERAPY; VERY ELDERLY; WHOLE BODY RADIATION; 18F-FDOPA PET; BRAIN METASTASES; BRAIN TUMOR; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; IMAGE PROCESSING; METASTASIS; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RADIOTHERAPY; RECURRENT DISEASE; TUMOR RECURRENCE; YOUNG ADULT;

18F-FDOPA PET; BRAIN METASTASES; RADIATION INJURY; RADIATION TREATMENT; TUMOR RECURRENCE;

ADULT; AGED; BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; DIHYDROXYPHENYLALANINE; DISEASE PROGRESSION; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEOPLASM METASTASIS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RADIATION INJURIES; RADIOTHERAPY; RECURRENCE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84894763441     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.121418     Document Type: Article

References (38)

1. Gavrilovic IT, Posner JB. Brain metastases: epidemiology and pathophysiology. J Neurooncol. 2005;75: 5-14.
2. Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol. 2004;22: 2865-2872.
3. Cavaliere R, Schiff D. Cerebral metastases: a therapeutic update. Nat Clin Pract Neurol. 2006;2: 426-436.
4. Oh Y, Taylor S, Bekele BN, et al. Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases. Cancer. 2009;115: 2930-2938.
5. Brogi E, Murphy CG, Johnson ML, et al. Breast carcinoma with brain metastases: clinical analysis and immunoprofile on tissue microarrays. Ann Oncol. 2011; 22: 2597-2603.
6. Meier S, Baumert BG, Maier T, et al. Survival and prognostic factors in patients with brain metastases from malignant melanoma. Onkologie. 2004;27: 145-149.
7. Ellis TL, Neal MT, Chan MD. The role of surgery, radiosurgery and whole brain radiation therapy in the management of patients with metastatic brain tumors. Int J Surg Oncol. 2012;2012: 952345.
8. Ruben JD, Dally M, Bailey M, Smith R, McLean CA, Fedele P. Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy. Int J Radiat Oncol Biol Phys. 2006;65: 499-508.
9. Levivier M, Becerra A, De Witte O, Brotchi J, Goldman S. Radiation necrosis or recurrence. J Neurosurg. 1996;84: 148-149.
10. Clarke JL, Chang S. Pseudoprogression and pseudoresponse: challenges in brain tumor imaging. Curr Neurol Neurosci Rep. 2009;9: 241-246.
11. Stockham AL, Tievsky AL, Koyfman SA, et al. Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery. J Neurooncol. 2012;109: 149-158.
12. Kang TW, Kim ST, Byun HS, et al. Morphological and functional MRI, MRS, perfusion and diffusion changes after radiosurgery of brain metastasis. Eur J Radiol. 2009;72: 370-380.
13. Chen W. Clinical applications of PET in brain tumors. J Nucl Med. 2007;48: 1468-1481.
14. Chao ST, Suh JH, Raja S, Lee SY, Barnett G. The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery. Int J Cancer. 2001;96: 191-197.
15. Ricci PE, Karis JP, Heiserman JE, Fram EK, Bice AN, Drayer BP. Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? AJNR Am J Neuroradiol. 1998;19: 407-413.
16. Tsuyuguchi N, Sunada I, Iwai Y, et al. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible? J Neurosurg. 2003;98: 1056-1064.
17. 11C]methionine (MET)-PET in patients with brain gliomas and metastases. Int J Radiat Oncol Biol Phys. 2011;81: 1049-1058.
18. 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Med. 2006;47: 904-911.
19. 18F]fluoro-L-dopa. Int J Rad Appl Instrum A. 1992;43: 989-996.
20. 18F]OF2. Nucl Med Biol. 1996;23: 189-199.
21. Bergström M, Litton J, Eriksson L, Bohn C, Blomqvist G. Determination of object contour from projections for attenuation correction in cranial positron emission tomography. J Comput Assist Tomogr. 1982;6: 365-372.
22. Kinahan PE, Townsend DW, Beyer T, Sashin D. Attenuation correction for a combined 3D PET/CT scanner. Med Phys. 1998;25: 2046-2053.
23. Nuyts J, Michel C, Dupont P. Maximum-likelihood expectation-maximization reconstruction of sonograms with arbitrary noise distribution using NEC-Transformations. IEEE Trans Med Imaging. 2001;20: 365-375.
24. Peterson AM, Meltzer CC, Evanson EJ, Flickinger JC, Kondziolka D. MR imaging response of brain metastases after gamma knife stereotactic radiosurgery. Radiology. 1999;211: 807-814.
25. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol. 1990;8: 1277-1280.
26. 18F]fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology. 1982;144: 885-889.
27. Fulham MJ, Brunetti A, Aloj L, Raman R, Dwyer AJ, Di Chiro G. Decreased cerebral glucose metabolism in patients with brain tumors: an effect of corticosteroids. J Neurosurg. 1995;83: 657-664.
28. 18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter. J Nucl Med. 2004;45: 1653-1659.
29. Horky LL, Hsiao EM, Weiss SE, Drappatz J, Gerbaudo VH. Dual phase FDGPET imaging of brain metastases provides superior assessment of recurrence versus post-Treatment necrosis. J Neurooncol. 2011;103: 137-146.
30. Heiss WD, Wienhard K, Wagner R, et al. F-DOPA as an amino acid tracer to detect brain tumors. J Nucl Med. 1996;37: 1180-1182.
31. 18F-FDOPA kinetics in brain tumors. J Nucl Med. 2007;48: 1651-1661.
32. Oldendorf WH, Szabo J. Amino acid assignment to one of the three blood-brain barrier amino acid carriers. Am J Physiol. 1976;230: 94-98.
33. Wade LA, Katzman R. Synthetic amino acids and the nature of L-DOPA transport at the blood-brain barrier. J Neurochem. 1975;25: 837-842.
34. Kumakura Y, Cumming P. PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches. Neuroscientist. 2009;15: 635-650.
35. 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med. 2008;49: 694-699.
36. 18F-fluoroethyl)-L-Tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis. J Nucl Med. 2012;53: 1367-1374.
37. Patil CG, Pricola K, Sarmiento JM, Garg SK, Bryant A, Black KL. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases. Cochrane Database Syst Rev. 2012;(9): CD006121.
38. 11C]methionine and rubidium-82 using PET. J Neurol Sci. 1995;132: 20-27.